Dean Regier retweetledi

I was so pleased to be part of a great team writing a commentary on the draft FDA guidelines on Bayesian clinical trial designs. Should have been done 30 years ago, but better late than never
JAMA@JAMA_current
💬 Perspective: Bayesian methodology supports efficient, flexible clinical trial designs; FDA guidance encourages prespecification and sensitivity analysis of priors. @f2harrell @d_spiegel ja.ma/47hHTyb
English


















